Author:
Yamaguchi Hiroshi,Nagumo Kiyoshi,Nakashima Taiji,Kinugawa Yoshikazu,Kumaki Satoru
Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology and Child Health
Reference13 articles.
1. Bangs ME, Hazell P, Danckaerts M, Hoare P, Coghill DR, Wehmeier PM, Williams DW, Moore RJ, Levine L (2008) Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. Pediatrics 121:314–320
2. Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA (2011) ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 365:1896–1904
3. Donnelly C, Bangs M, Trzepacz P, Jin L, Zhang S, Witte MM, Ball SG, Spencer TJ (2009) Safety and tolerability of atomoxetine over 3 to 4 years in children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry 48:176–185
4. Eli Lilly and Company (2013) Prescribing information on Strattera, pp 1–17. http://pi.lilly.com/us/strattera-pi.pdf
5. Eli Lilly and Company (2009) Press release information on Strattera. https://www.lilly.co.jp/pressrelease/2009/news_2009_013.aspx
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献